• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1994 Fiscal Year Final Research Report Summary

Molecular biological analysis for gene therapy of the thrombosis and hemostatic

Research Project

Project/Area Number 05304036
Research Category

Grant-in-Aid for Co-operative Research (A)

Allocation TypeSingle-year Grants
Research Field Hematology
Research InstitutionHIROSHIMA UNIVERSITY

Principal Investigator

KURAMOTO Atsushi  Research Institute for Radiation Biology and Medicine, Hiroshima University Professor, 原爆放射能医学研究所, 教授 (50034070)

Co-Investigator(Kenkyū-buntansha) SAITO Hidehiko  Nagoya Univ.Shool of Med.Professor, 医学部, 教授 (20153819)
OKUMA Minoru  Kyoto Univ.Faculty of Med.Int.Med.Professor, 医学部, 教授 (50026986)
IWANAGA Sadaaki  Kyushu Univ.Faculty of Science Professor, 理学部, 教授 (90029942)
TITANI Koichi  Fujita Health Univ.shool of Med.Professor, 総合医科学研究所, 教授 (60179942)
SUZUKI Koji  Mie Univ.Faculty of Med.Molecular Boil.Professor, 医学部, 教授 (70077808)
Project Period (FY) 1993 – 1994
Keywordsregulator of coagulation factor / gene therapy / gene analysis / platelet membrane receptor / extrinsic coagulation pathway / apolipoprotein / NF-KB / thransfer treatment of antisense ligomer
Research Abstract

The fundamental investigation for gene therapy and molecular biological analysis to regulation factor of thrombin, coagulation factor and apoprotein system, platelet membrane receptor, and endothelial systems progressed as follows.
1.The gene analysis of protein C,protein S and alpha2-plasmin inhibitor abnormalities or deficiency which repeat thrombosis, and the hereditary platelet functional abnormalities include the Bernard-Soulier syndrome(BSS), adhesion function deficinecy due to the low expression or defect of GPIb/IX-V and thromboxan A2 receptor abnormalites which show the bleeding tendency were studied.
These studies have made clear the functional abnormality sites of these coagulation regulation factors or receptors and the mechanism of secretion abnormalities or receptor expression deficiency of these diseases.
The specific functional domain of GPIIb/IIIa(fibrinogen receptor)for fibrinogen binding was explained by using recombinant gene technology.
These researches will contribute … More the explanation of target for gene therapy of these hereditary disease, the production of recombinant protein with high quality and function and the development of new anti thrombotic agents.
2.The interaction domain between coagulation factor VII and tissue factor(TF)in extrinsic coagulation pathway and the transcription mechanism of apolipoprotein gene were examined. These studies will link into the therapy for prevention of thrombosis.
3.The inflammatory cytokines which were secreted from endothelial cells by the stimulation of endotoxin, thrombin or TNF and the proliferation of endothelial smooth muscle cells by thrombin were important factor for the development of atherosclerosis and thrombosis.
The secretion of the inflammatory cytokines and the proliferation of smooth muscle cells were induced by the transcription factor NF-KB.On the other hand, these reactions were inhibited by transfer the antisense NF-KB oligomer to endothelial cells. This sntisense therapy explained the effectiveness for the prevention of atherosclerosis, thrombosis and the development of DIC. Less

  • Research Products

    (66 results)

All Other

All Publications (66 results)

  • [Publications] Kuramoto A.et al: "Expression of platelet membrane glylcoprotein V in human megakaryocytes and megakaryocytic cell lines:A study using a novel monoclonal antibody against GPV." Thromb Haemost.72. 762- (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kuramoto A.et al: "Nonsense mutation in the glycoprotein IX coding sequence associated with Bernard-Soulier syndromle." Blood. 82. 472a- (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kuramoto A.et al: "Precise diagnosis by gene analysis and successful management of delivery in three patients with type IIB von Willebrand disease." Int J Haemat. 60. 163- (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hirosawa S.et al: "Secretion of α2-plasmin inhibitor is impaired by amino acid deletion in a small region of the molecule." J.Biochem.115. 293-297 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Titani K.et al: "C-type galactoside-binding lectin from Bothrops jararaca venom:comparison of its structure and function with botrocetin." Arch.Biochem.Biophys.308. 306-310 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Titani K.et al: "Purification and characterization of bothrombin,a fibrinogen-clotting serine protease from the venom of Bothrops jararaca." Biochemistry. 33. 1843-1849 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Titani K.et al: "Immuno-enzymometric analysis for plasma von Willebrand factor degradation in diabetes mellitus using monoclonal antibodies recognizing protease-sensitive sites." Clinical Biochem.27. 123-131 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Titai K.et al: "A 28kDa-protein with disintegrin-like structure(Jararhagin-C) purified from Bothrops jararaca venom inhibits collagen-and ADP-induced platelet aggregation." Biochem.Biophys.Res.Commun.201. 331-339 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Titani K.et al: "Structural elements influencing von Willebrand factor (vWF) bindilng affinity for platelet glycoprotein Ib within a dispase-digested vWF fragment." Blood. 84. 1553-1558 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Titani K.et al: "Alternatively-spliced isoform of P-selectin is present in vivo as a soluble molecule." J.Biol.Chem.269. 23708-23715 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Titani K.et al: "Fibronectin and 130-kDa molecule complex mimics snake venom botrocetin-like structure." J.Biochem.(in press). (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Titani K.et al: "Isolation and characterizaion of Bothrops jararaca GPIb-BP,a snake venom antagonist specific to platelet glycoprotein Ib." Thromb.Haemostas.(in press). (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Titani K.et al: "ABO blood group genotype and plasma von Willebrand factor in normal individuals." Vox Sang.(in press). (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Okuma M,et al: "Arg^<60> to Leu mutation of the human thromboxane A_2 receptor in a dominantly inherited bleeding disorder." J.Clin.Invest.94. 1662-1667 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 大熊 稔: "血小板機能異常症" 日内会誌. 83. 259-264 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Saito H.et al: "Impaired human tissue factor-mediated activity in blood clotting factor VII Nagova(Arg304 to Trp)" J.Biol.Chem.269. 7355-7363 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Saito H.et al: "Humoral and cellular immunity to an encoded protein induced by direct DNA injection." Human gene therapy. 5. 1335-1339 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suzuki K.et al: "Factor VII Mie:Homozygous asymptomatic type I deficiency caused by an amino acid substitution of His(CAC) for Arg(247)(CGC)in the catalvtic domain." Thromb.Haemostas.71. 773-777 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suzuki K.et al: "The role of human factor X activation peptide in activation of factor X by factor IXa." J.Biochem.116. 335-340 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suzuki K.et al: "Receptor-mediated endocytosis of thrombin-antithrombin III complex by the human monocvtoid cell line U937." Biochem.Biphys.Res.Commun.200. 1334-1340 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suzuki K.et al: "The thrombin receptor transmits siggnals through a 330Kda protein kinase in human platelets." Biochem.Biophys.Res.Commun.302. 907-913 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suzuki K.et al: "Blood coagulation factor Xa interacts with a linear sequence of the kringle 2 domain of prothrombin." J.Biochem.116. 589-597 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suzuki K.et al: "Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance hemodialvsis." Blood Coag.Fibrinol.5. 731-717 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suzuki K.et al: "Protein S-Tokushima: Abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S." Blood. 83. 683-690 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maruyama I.et al: "Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats.21GC25:Am.J.Hematol." 45. 293-303 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maruyama I.et al: "Effect of recombinant human soluble thrombomodulin(rhs-TM)on a rat model of disseminated intravascular coagulation with decreased level of plasma antithrombin III." Thromb.Haemost.71. 452-455 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Maruyama I.et al: "Thrombin receptor agonist peptide decreases thrombomoduliln activity in cultured human umbilical vein endothelial cells." Biocherm.Biophys.Comm.199. 1262-1269 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kitajima I,et al: "Transcriptional suppression of the HTLV-1 LTR occurs by an unconventional interaction of a CREB with R region." Mol.Cell.Biol.14. 5371-5383 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kitajima I.et al: "E5510 antagonizes thrombin receptor singles by inhibiting NF-kB activation." Biocherm.Biphys.Res.Comm.203. 1181-1187 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kitajima I.et al: "Nitric oxide-mediated apoptosis in murine mastocytoma." Biocherm.Biophys.Res.Comm.204. 244-251 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kitajima I.et al: "Involvement of NF-kB activation in thrombin-induced human smooth muscle cell proliferation." Biocherm.Biophys.Res.Comm.204. 950-955 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kitajima I.et al: "Genomic footprinting of the HTLV-1 LTR in a transgenic mouse tumorigenesis model." Transgene. (in pressa). (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sakata Y.et al: "Effet of glycosidase inhibitors on the biosynthesis,of α2-plasmin inhibitor and antithrombin III." Biochim.Biophys.Acta.1226. 300-306 (1994)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kuramoto A.et al: "Expression of platelet membrane glycoprotein V in human megakaryocytes and megakaryocytic cell lines : A study using a novel monoclonal antibody against GPV." Thromb Haemost. 72. 762 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kuramoto A.et al: "Nonsense mutation in the glycoprotein IX coding sequence associated with Bernard-Soulier syndrome." Blood. 84. 472a (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kuramoto A.et al: "Percise diagnosis by gene analysis and successful management of delivery in three patients with type IIB von willebrand disease." Int J Haemat. 60. 163 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hirosawa S.et al: "Secretion of alpha2-plasmin inhibitor is impaired by amino acid deletion in a small region of the molecule." J.Biochem. 115. 293-297 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Titani k.et al: "C-type galactoside-binding lectin from Bothrops jararaca venom : comparison of its structure and function with botrocetin." Arch.Biochem Biophys. 308. 306-310 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Titani K.et al: "Purification and characterzation of bothrombin, a fibrinogen-clotting serine protease from the venom of Bothrops jararaca." Biochemistry. 33. 1843-1849 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Titani K.et al: "Immuno-enzymometric analysis for plasma von Willebrand factor degradation in diabetes mellitus using monoclonal antibodies recognizing protease-sensitive sites." Clinical Biochem. 27. 123-131 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Titai K et al: "A 28kDa-protein with disintegrin-like structure(Jararhagin-C)purified from Bothrops jararaca venom inhibits collagen-and ADP-induced platelet aggregation." Biochem.Biophys.Res.Commun. 201. 331-339 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Titani, et al: "Structural elements influencing von Willebrand factor(vWF)binding affinity for platelet glycoprotein Ib within a dispase-digested vWF fragment." Blood. 84. 1553-1558 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Titani K et al: "Alternatively-spliced isoform of P-selectin is present in vivo as a soluble molecule." J.Biol.Chem. 269. 23708-23715 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Titani K et al: "Fibronectin and 130-kDa molecule complex mimics snake venom botrocetin-like structure." J.Biochem. (in press). (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Titani K et al: "Isolation and characterization of Bothrops jararaca GPIb-BP,a snake venom antagonist specific to platelet glycoprotein Ib." Thromb.Haemostas. (in press). (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Titani K et al: "ABO blood group genotype and plasma von Willebrand factor in normal individuals." Vox Sang. (in press). (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Okuma M,et al: "Arg_<60> to Leu mutation of the human thromboxane A^2 receptor in a dominantly inherited bleeding disorder." J.Clin.Invest. 94. 1662-1667 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Okuma M,et al: "Platelet functional disorders." J.Jap.Soc.Int Med. 83. 259-264 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Saito H.et al: "Impaired human tissue factor-mediated activity in blood clotting factor VII Nagoya(Arg304 to trp)" J.Biol.Chem. 269. 7355-7363 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Saito H.et al: "Humoral and cellular immunity to an encoded protein induced by direct DNA injection." Human gene therapy. 5. 1335-1339 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Suzuki K.et al: "Factor.VII Mie : Homozygous asymptomatic type I deficiency caused by an amino acid substitution of His(CAC)for Arg(247)(CGC)in the catalytic domain." Thromb.Haemostas. 71. 773-777 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Suzuki K.et al: "The role of human factor X activation peptide in activation of factor X by factor IXa." J.Biochem. 116. 335-340 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Suzuki K.et al: "Receptor-mediated endocytosis of thrombin-antithrombin III complex by the human monocytoid cell line U937." Biochem.Biphys.Res.Commun. 200. 1334-1340 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Suzuki K.et al: "The thrombin receptor transmits siggnals through a 330Kde protein kinase in human platelets." Biochem.Biphys.Res.Commun. 302. 907-913 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Suzuki K.et al: "Blood coagulation factor Xa interacts with a linear sequence of the kringle 2 domain of prothrombin." J.Biochem. 116. 589-597 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Suzuki K.et al: "Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance hemodialysis." Blood Coag.Fibrinol. 5. 731-717 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Suzuki K.et al: "Protein S-Tokushima : Abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S." Blood. 83. 683-690 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maruyama I.et al: "Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced dissminated intravascular coagulation in rats." Am.J.Hematol. 45. 298-303 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maruyama I.et al: "Effect of recombinant human soluble thrombomodulin(rhs-TM)on a rat model of disseminated intravascular coagulation with decreased level of plasma antithrombin III." Thromb.Haemost. 71. 452-455 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Maruyama I.et al: "Thrombin receptor agonist peptide decreases thrombomodulin activity in cultured human umbilical vein endothelial cells." Biochrm.Biophys.Res.Comm. 199. 1262-1269 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitajima I.et al: "Transcriptional suppression of the HTLV-1 LTR occurs by an unconventional interaction of a CREB with R region." Mol.Cell.Biol. 14. 5371-5383 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitajima I.et al: "E5510 antagonizes thrombin receptor singles by inhibiting NF-kB activation." Biocherm.Biophys.Res.Comm. 203. 1181-1187 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitajima I.et al: "Nitric oxide-mediated apoptosis in murine mastocytoma." Biocherm.Biophys.Res.Comm. 204. 244-251 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitajima I.et al: "Involvement of NF-kB activation in thrombin-induced human smooth muscle cell proliferation." Biocherm.Biophys.Res.Comm. 204. 950-955 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kitajima I.et al: "Genomic footprinting of the HTLV-1 LTR in a transgenic mouse tumorigenesis model." Transgene. (in press). (1994)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sakata Y.et al: "Effect of glycosidase inhibitors on the biosynthesis, of alpha2-plasmin inhibitor and antithrombin III." Biochim.Biophys.Acta. 1226. 300-306 (1994)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1996-04-15  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi